Medical Research Council Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.
Nat Genet. 2012 Sep;44(9):991-1005. doi: 10.1038/ng.2385. Epub 2012 Aug 12.
Through genome-wide association meta-analyses of up to 133,010 individuals of European ancestry without diabetes, including individuals newly genotyped using the Metabochip, we have increased the number of confirmed loci influencing glycemic traits to 53, of which 33 also increase type 2 diabetes risk (q < 0.05). Loci influencing fasting insulin concentration showed association with lipid levels and fat distribution, suggesting impact on insulin resistance. Gene-based analyses identified further biologically plausible loci, suggesting that additional loci beyond those reaching genome-wide significance are likely to represent real associations. This conclusion is supported by an excess of directionally consistent and nominally significant signals between discovery and follow-up studies. Functional analysis of these newly discovered loci will further improve our understanding of glycemic control.
通过对无糖尿病的欧洲血统个体进行全基因组关联荟萃分析,样本量高达 133010 人,其中包括使用 Metabochip 新进行基因分型的个体,我们将影响血糖特征的已确认基因座数量增加到 53 个,其中 33 个也增加了 2 型糖尿病的风险(q < 0.05)。影响空腹胰岛素浓度的基因座与血脂水平和脂肪分布有关,表明其对胰岛素抵抗有影响。基于基因的分析确定了进一步具有生物学意义的基因座,表明除了达到全基因组显著水平的基因座外,还有可能存在其他真正的关联基因座。这一结论得到了发现和后续研究之间存在大量方向一致且具有名义显著性信号的支持。对这些新发现的基因座进行功能分析将进一步提高我们对血糖控制的理解。